These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 15236661)

  • 41. Drug treatment of psychiatric patients in general practice.
    Tyrer P
    Br Med J; 1978 Oct; 2(6143):1008-10. PubMed ID: 709177
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prescription patterns for psychotropic drugs in cancer patients; a large population study in the Netherlands.
    Ng CG; Boks MP; Smeets HM; Zainal NZ; de Wit NJ
    Psychooncology; 2013 Apr; 22(4):762-7. PubMed ID: 22351591
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Psychotropic drug use and correspondence with psychiatric diagnoses in the mental health in the general population survey].
    Grolleau A; Cougnard A; Bégaud B; Verdoux H
    Encephale; 2008 Sep; 34(4):352-9. PubMed ID: 18922237
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevalence, Patterns and Predictors of Psychotropic Polypharmacy Among Elderly Individuals with Parkinson's Disease In Long Term Care Settings In The United States.
    Bhattacharjee S; Goldstone L; Warholak T
    J Parkinsons Dis; 2016; 6(1):247-55. PubMed ID: 26756742
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Single and combined psychotropic medication use in a child and adolescent mental health service.
    Reed E; Vance A; Luk E; Nunn K
    Aust N Z J Psychiatry; 2004 Apr; 38(4):204-11. PubMed ID: 15038798
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Longitudinal prescribing patterns for psychoactive medications in community-based individuals with developmental disabilities: utilization of pharmacy records.
    Lott IT; McGregor M; Engelman L; Touchette P; Tournay A; Sandman C; Fernandez G; Plon L; Walsh D
    J Intellect Disabil Res; 2004 Sep; 48(Pt 6):563-71. PubMed ID: 15312057
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prevalence, Time Trends, and Utilization Patterns of Psychotropic Polypharmacy Among Pediatric Medicaid Beneficiaries, 1999-2010.
    Soria Saucedo R; Liu X; Hincapie-Castillo JM; Zambrano D; Bussing R; Winterstein AG
    Psychiatr Serv; 2018 Aug; 69(8):919-926. PubMed ID: 29879872
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Mental disease, existence of diagnostic, use of psychotropic medication: differences by autonomous communities under the national health survey 2006].
    Ricci-Cabello I; Ruiz-Pérez I; Plazaola-Castaño J; Montero-Piñar I
    Rev Esp Salud Publica; 2010; 84(1):29-41. PubMed ID: 20376411
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Physician Care Coordination and the Use of Psychotropic Polypharmacy in the Management of Pediatric Mental Disorders.
    Medhekar R; Fujimoto K; Aparasu RR; Bhatara VS; Johnson ML; Alonzo JP; Schwarzwald HL; Chen H
    J Manag Care Spec Pharm; 2019 Jan; 25(1):29-38. PubMed ID: 30589632
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Managing interactions between cognitive enhancers and other psychotropics.
    Tang SW; Tang WH; Leonard BE
    Int Clin Psychopharmacol; 2017 Jul; 32(4):175-183. PubMed ID: 28234656
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Poor agreement amongst psychiatrists assessing rationality in five cases of psychiatric polypharmacy.
    Lochmann van Bennekom MW; Gijsman HJ; de Beurs E; Zitman FG
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 May; 32(4):1069-71. PubMed ID: 18343550
    [No Abstract]   [Full Text] [Related]  

  • 52. Effects of polypharmacy on outcome in patients with schizophrenia in routine psychiatric treatment.
    Längle G; Steinert T; Weiser P; Schepp W; Jaeger S; Pfiffner C; Frasch K; Eschweiler GW; Messer T; Croissant D; Becker T; Kilian R
    Acta Psychiatr Scand; 2012 May; 125(5):372-81. PubMed ID: 22321029
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Merits and Demerits of High-dose Psychotropic Polypharmacy in Schizophrenia from Guidelines].
    Hashimoto R; Yasuda Y; Fujimoto M; Yamamori H
    Seishin Shinkeigaku Zasshi; 2017; 119(3):185-191. PubMed ID: 30620854
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Polypharmacy in a hospitalized psychiatric population: risk estimation and damage quantification.
    Carmona-Huerta J; Castiello-de Obeso S; Ramírez-Palomino J; Duran-Gutiérrez R; Cardona-Muller D; Grover-Paez F; Fernández-Dorantes P; Medina-Dávalos R
    BMC Psychiatry; 2019 Feb; 19(1):78. PubMed ID: 30791883
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Psychotropic prescription practices in child psychiatric inpatients 9 years old and younger.
    Lekhwani M; Nair C; Nikhinson I; Ambrosini PJ
    J Child Adolesc Psychopharmacol; 2004; 14(1):95-103. PubMed ID: 15142396
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Perceived Health Control: A Promising Step Forward in Our Understanding of Treatment Adherence in Psychiatric Care.
    De Las Cuevas C; Peñate W; Cabrera C
    J Clin Psychiatry; 2016 Oct; 77(10):e1233-e1239. PubMed ID: 27529827
    [TBL] [Abstract][Full Text] [Related]  

  • 57. National Trends in Psychiatric Not Otherwise Specified (NOS) Diagnosis and Medication Use Among Adults in Outpatient Treatment.
    Rajakannan T; Safer DJ; Burcu M; Zito JM
    Psychiatr Serv; 2016 Mar; 67(3):289-95. PubMed ID: 26567936
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neuropsychiatric diagnosis and psychotropic medication prescription patterns in a mental hospital-based child and adolescent psychiatric service in Nigeria.
    Bakare MO; Igwe MN; Odinka PC; Iteke O
    J Health Care Poor Underserved; 2011 Aug; 22(3):751-5. PubMed ID: 21841276
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prescription of psychotropic drugs in adolescent psychiatry wards in Finland.
    Haapasalo-Pesu KM; Erkolahti R; Saarijärvi S; Aalberg V
    Nord J Psychiatry; 2004; 58(3):213-8. PubMed ID: 15204208
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A one-day survey of characteristics of off-label hospital prescription of psychotropic drugs.
    Martin-Latry K; Ricard C; Verdoux H
    Pharmacopsychiatry; 2007 May; 40(3):116-20. PubMed ID: 17541887
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.